Markets:

Overview

News

Currencies

International

Treasuries

Revive Therapeutics Ltd (OP:RVVTF)

0.0078 +0.0006 (+8.33%)

Streaming Delayed Price Updated: 3:42 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revive Therapeutics Ltd

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week ↗

September 11, 2021

The performance of the psychedelic-focused index components substantially outshone the weed stocks.

Via Talk Markets

Topics Cannabis

Marijuana Drug Stocks: All You Need To Know Is Here! ↗

August 13, 2021

Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market...

Via Talk Markets

Topics Cannabis

These OTC Securities Had the Most Trading Activity in July ↗

August 06, 2021

Photo by Federico Beccari on Unsplash In July, O...

Via Benzinga

Marijuana And Mushroom Stock Category Down 4% In July; Now +24% YTD ↗

August 01, 2021

We detail how he pot- and psychedelic-related stock sector performed in the last week, during the month of July, and YTD and the stocks that moved +/-5% last week, and why.

Via Talk Markets

Topics Cannabis

Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries ↗

April 20, 2021

In recent years, there has been a re-emergence in the study of psychedelic drug...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Marijuana Vs. Mushroom Psychedelic Drug Stocks: A Current & YTD Performance Comparison ↗

July 24, 2021

We identify the performance of the top 8 clinical-stage psychedelic companies in each of the marijuana and mushroom drug stock categories during the past 5 trading days, July to date, and YTD.

Via Talk Markets

Topics Cannabis

Pot Stocks Down In June - Remain +29.6% YTD ↗

July 04, 2021

There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each...

Via Talk Markets

Topics Cannabis

The Cannabis-Centric BioPharma Stocks Index Declined In April But Remains Up YTD ↗

May 05, 2021

13 cannabis-centric clinical-stage biopharmaceutical companies and their major operational activities in April to assist those considering investing in this marijuana sub-category,

Via Talk Markets

Topics Cannabis

Majority Of Pure-Play Psychedelic Drug Stocks Went Up Last Week ↗

April 26, 2021

41 psychedelic drug stocks trade on the various North American stock exchanges and in the past week 24 went up, 12 went down and 5 had no change in price.

Via Talk Markets

Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week ↗

April 25, 2021

Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.

Via Talk Markets

Pure-Play Psychedelic Drug Stocks Index Declined 5.7% This Week ↗

April 17, 2021

In the past week, of the 41 psychedelic drug stocks that trade on the various North American stock exchanges only nine went up, in price while 31 went down and one had no change.

Via Talk Markets

Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027

April 14, 2021

Via FinancialNewsMedia

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.